Press Releases

Aug 12, 2021

Nobelpharma signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX®

read more Nobelpharma signs a License Agreement for ProBioGen’s Vaccine Manufacturing Platform AGE1.CR.pIX®

download PDF

Jul 27, 2021

ValenzaBio partners with ProBioGen to maximize cell line productivity and licenses GlymaxX®

read more ValenzaBio partners with ProBioGen to maximize cell line productivity and licenses GlymaxX®

download PDF

Jul 13, 2021

Heat Biologics enters into Research License Agreement for ProBioGen's Transposase System and Suspension HEK293 Cell Line

read more Heat Biologics enters into Research License Agreement for ProBioGen's Transposase System and Suspension HEK293 Cell Line

download PDF

Jun 22, 2021

ProBioGen and LAVA Therapeutics N.V. sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific

read more ProBioGen and LAVA Therapeutics N.V. sign Agreement for Cell Line Development for Manufacturing of a Novel Bispecific

download PDF

Jun 09, 2021

City of Hope takes a Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

read more City of Hope takes a Commercial Product License to use ProBioGen’s AGE1.CR® Vaccine Manufacturing Platform

download PDF

May 27, 2021

ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH – A Healthcare Transforming Medicines Company

read more ProBioGen and Minapharm Pharmaceuticals incorporate MiGenTra GmbH – A Healthcare Transforming Medicines Company

download PDF

May 27, 2021

ProBioGen und Minapharm Pharmaceuticals gründen die MiGenTra GmbH mit dem Ziel, das Gesundheitswesen zu verändern

read more ProBioGen und Minapharm Pharmaceuticals gründen die MiGenTra GmbH mit dem Ziel, das Gesundheitswesen zu verändern

download PDF

Apr 26, 2021

Asher Biotherapeutics contracts ProBioGen to develop and manufacture their Lead Candidate

read more Asher Biotherapeutics contracts ProBioGen to develop and manufacture their Lead Candidate

download PDF

Apr 15, 2021

Nouscom activates Commercial Product License for ProBioGen’s proprietary Vaccine Production Cell Line AGE1.CR.pIX®

read more Nouscom activates Commercial Product License for ProBioGen’s proprietary Vaccine Production Cell Line AGE1.CR.pIX®

download PDF

Mar 24, 2021

ProBioGen enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project

read more ProBioGen enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project

download PDF

Page 2 of 10

Previous
1
2
3
4
5
6
7
Next
Last »

ProBioGen News

Join our news and always be up-to-date.

Sign up